Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shadomy

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Clinical Pharmacology and Therapeutics|November 1, 1974
Fungal infectionsJ P Utz, S Shadomy
Journal of Clinical Microbiology|August 1, 1982
In vitro studies with cefotaxime: disk diffusion susceptibility testsS Shadomy, E L Chan
European Journal of Clinical Microbiology|June 1, 1983
Disk diffusion susceptibility tests with norfloxacin: confirmation of proposed interpretive criteriaS J Wood, S Shadomy
Antimicrobial Agents and Chemotherapy|January 1, 1981
N-formimidoyl thienamycin (MK0787): in vitro studyS Shadomy, R S May
Diagnostic Microbiology and Infectious Disease|January 1, 1991
Comparative in vitro antifungal susceptibility studies with 30 serotype A and B isolates of Candida albicansS Shadomy, H J Shadomy
Antimicrobial Agents and Chemotherapy|February 1, 1977
Effects of purines and pyrimidines on the fungistatic activity of 5-fluorocytosine in Aspergillus speciesG E Wagner, S Shadomy
The Journal of Infectious Diseases|June 1, 1977
Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testingC J Utz, S Shadomy
Chemotherapy|January 1, 1979
Studies on the mode of action of 5-fluorocytosine in Aspergillus speciesG E Wagner, S Shadomy
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1989
In vitro and in vivo evaluation of antifungal agentsA Espinel-Ingroff, S Shadomy
Antimicrobial Agents and Chemotherapy|March 1, 1978
In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandoleS Shadomy, G Wagner, M Carver
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|November 1, 1974
Fungal infectionsJ P Utz, S Shadomy
Journal of Clinical Microbiology|August 1, 1982
In vitro studies with cefotaxime: disk diffusion susceptibility testsS Shadomy, E L Chan
European Journal of Clinical Microbiology|June 1, 1983
Disk diffusion susceptibility tests with norfloxacin: confirmation of proposed interpretive criteriaS J Wood, S Shadomy
Antimicrobial Agents and Chemotherapy|January 1, 1981
N-formimidoyl thienamycin (MK0787): in vitro studyS Shadomy, R S May
Diagnostic Microbiology and Infectious Disease|January 1, 1991
Comparative in vitro antifungal susceptibility studies with 30 serotype A and B isolates of Candida albicansS Shadomy, H J Shadomy
Antimicrobial Agents and Chemotherapy|February 1, 1977
Effects of purines and pyrimidines on the fungistatic activity of 5-fluorocytosine in Aspergillus speciesG E Wagner, S Shadomy
The Journal of Infectious Diseases|June 1, 1977
Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testingC J Utz, S Shadomy
Chemotherapy|January 1, 1979
Studies on the mode of action of 5-fluorocytosine in Aspergillus speciesG E Wagner, S Shadomy
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1989
In vitro and in vivo evaluation of antifungal agentsA Espinel-Ingroff, S Shadomy
Antimicrobial Agents and Chemotherapy|March 1, 1978
In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandoleS Shadomy, G Wagner, M Carver
Pageof 9